We aim to make surgery faster, safer, and smarter
Our Values
Rooted in great science
Enhatch was born from years of experience designing medical implants and instruments in well-known organizations like Stryker Orthopedics., Tornier, and others.
Track record of success
Our leaders launched successful global implant systems at Stryker Orthopedics like Scorpio NRG Knee. We also developed next-gen shoulder implants systems for Nexa Orthopedics (acquired by Tornier).
A passion for innovation
Our goal is to create a faster, more accurate, and safer surgical experience for the millions of patients who will undergo life-saving surgeries every day.
Our Customer include
Our Customers Include
Our Investors
3D Systems is a leading additive manufacturing solutions partner. 3D Systems manufactures over two million implants and instruments for 100+ FDA- cleared and CE- market devices.
The Company has FDA - registered , ISO 13485- certified facilites in Colorado, USA and Belgium.
Numeta Capital invests in high-growth companies in the cloud software industry, offering a unique combination of operational, strategic, technology, and financial insight to companies seeking growth capital and expertise to scale on a global basis.
The firm seeks to invest $10M-$100M in established businesses with a proven technology and business model, and the proper fit in terms of customer-centric, product-driven values, via minority, majority, and structured equity transactions.
Apis Holdings is a private equity firm that makes multi-stage, growth-oriented investments in software, data, and tech-enabled services.
The Oklahoma - based firm also manages the George Kaiser Family Foundation(GKFF) investment portfolio.
We are delighted to announce strategic investment in Enhatch. Our vision to transform healthcare with additive manufacturing solutions is closely aligned with Enhatch's excellence in creating fully customized workflows that drive scalability for patient specific implants and instruments. Combined with Enhatch, our fully integrated approach makes it easier for our partners to adopt and augment their portfolios with personalized medical devices in a more efficient, cost-effective manner. It's part of our ongoing commitment to innovation and helps ensure our customers are at the forefront of medical device development and healthcare delivery. Together, we look forward to a future where precision and efficiency redefine the surgical landscape.
We are excited to partner with Enhatch, a company at the forefront of surgical innovation. Harnessing the power of artificial intelligence, Enhatch is well-poised to redefine the surgical landscape for medical device companies, distributors, and point-of-care facilities. Intelligent surgeries are the future, and we believe Enhatch can help us get there with AI-driven precision and efficiency.
Our strategic investment in Enhatch reflects our confidence in their mission to revolutionize surgeries, making them faster, safer, and smarter. The Enhatch team brings a wealth of medical device industry experience to the table, and they are seeing great customer traction. This aligns perfectly with our vision for impactful investments. We are excited to be a part of the Enhatch journey as they drive transformative change in the overburdened healthcare industry.
Our Leaders
Michael Phipps
Kevin Sichler
Jonathan Nickle
